Ozempic and Wegovy may strengthen bones in Type 2 diabetes patients, study finds

Type 2 diabetes patients on Ozempic and Wegovy -- which contain the active ingredient semaglutide -- were 15% less likely to suffer bone fractures than those on other weight-loss drugs, researchers say.